SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE
AND UNDIAGNOSED ENCEPHALITIS CASES.
GUIDELINES FOR HIGH RISK
OR POTENTIALLY HIGH-RISK
AUTOPSY CASES.
DRAFT COPY ONLY.
(Procedure 213).
http://www.netautopsy.org/axsop/axsop213.htm


NEXT PAGE
PREVIOUS PAGE
RETURN TO TABLE OF CONTENTS

United States Government Work, uncopyrighted, public-domain, DRAFT COPY ONLY. This document does not necessarily represent the views or policies of any United States Government agency. This document is provided "as is", without warranty of any kind, express or implied, including but not limited to the warranties of merchantability, fitness for a particular purpose and non-infringement. In no event shall the authors be liable for any claim, damages or other liability, whether in an action of contract, tort or otherwise, arising from, out of, or in connection with the document or the use or other dealings made with the document.

See also: Infection Control Policies: 036, 136, 216, 217.

PRINCIPLE OF THE TEST.


      Proper cautionary measures are necessary in the prevention of exposure to Creutzfeldt-Jakob disease.

SPECIMEN REQUIRED.


      At the Veterans Affairs Medical Health Care System (VAMHCS), autopsies are performed on deceased patients with a valid Authorization for Autopsy (U. S. Standard Form 523), a complete hospital chart, and a death note signed by a physician included in the chart.

REAGENTS, INSTRUMENTATION.


      Protective garments. Formic acid (see below).

STEP-BY-STEP DESCRIPTION.
SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE AND UNDIAGNOSED ENCEPHALITIS CASES. by Oscar A. Iseri, M.D.

INTRODUCTION. Creutzfeldt-Jakob disease (CJD) is a fatal dementing disorder of humans.

1. Clinical diagnosis is based upon a history of rapidly progressive dementia, presence of myoclonic movements, and a characteristic electroencephalogram.

2. Diagnostic overlap with Alzheimer's disease and other atypical dementing diseases.

3. At autopsy, most patients with classic Creutzfeldt-Jakob disease show some spongiform change in brain tissue.

4. Creutzfeldt-Jakob disease are characterized by presence of prion protein (PrP), which is probably the infective agent.

5. Incubation period may be from months to decades, but once symptoms develop, the disorder is usually fatal within one year.

6. CJD is apparently not spontaneously contagious, but there have been instances of iatrogenic transmission, e.g., corneal transplants from a diseased patient.

7. CJD has been reported in histology technicians and in a pathologist, but epidemiologic studies have repeatedly failed to demonstrate an excess incidence of CJD in health care workers or in autopsy room personnel.

8. There is a possible risk of transmission of CJD from Bovine Spongiform Encephalopathy, reported in Great Britain. Since CJD can only be confirmed at autopsy, further study of CJD from autopsy materials is important.

9. The CJD agent is killed by steam-autoclaving at 136 degrees Celsius for one hour. Disinfectants such as 10% bleach and 2N sodium hydroxide have been claimed to disinfect the agent, but there is evidence that they may not.

10. The following procedures use the 10% bleach solution, which is at least partially effective, but which is more convenient to use among the two.

PROCEDURE.

1. Personnel should be limited to the Prosector and Autopsy Assistant.

2. Attire includes double long-sleeved surgical gowns, double surgical gloves, wire-mesh gloves are advisable, Air-Mate Hepa system powered air-purifying personal respirator, goggles, waterproof apron, and shoe covers.

3. The room is prepared with appropriate surgical instruments and cleared of all unnecessary items in order to minimize surface exposure.

4. The room entrance is provided with a bleach-soaked foot mat (10% bleach).

5. The cadaver is transferred to the autopsy room in a plastic body bag and placed on the autopsy table.

6. The upper body is uncovered. Blood is obtained by intracardiac puncture and transferred to vacutainers for centrifugation. Serum is removed with a syringe to cryogenic vials, sealed, and placed in -70 degrees Celsius storage.

7. With only the head uncovered, cerebrospinal fluid (CSF) is obtained by propping the head forward, flexed toward the chest, and inserting a long-shaft needle immediately beneath the occipital region penetrating into the basal cerebellomedullary cistern (cisterna magna). The CSF is collected and transferred to cryogenic vials which are stored in a -70 degrees Celsius freezer.

8. The skin of the scalp is incised and reflected in the usual manner. The skull is carefully opened with a Stryker Saw, WHILE SURROUNDED BY A TRANSPARENT PLASTIC ENCLOSURE. IT IS ADVISABLE TO USE A WET TOWEL OVER THE SAW TO TRAP BONE DUST AND DEBRIS. CARE IS TAKEN TO AVOID CUTTING THE BRAIN TISSUE WITH THE SAW. THE SKULL CAP IS THEN CAREFULLY REMOVED TO PREVENT INJURY TO THE FINGERS OF PERSONNEL AND TO KEEP TISSUES AS STERILE AS POSSIBLE. THE BRAIN IS REMOVED BY STERILE SCALPEL, PLACED IN A STERILE STAINLESS STEEL PAN, AND WEIGHED. With the brain removed, the skull cap is reinstated and the scalp sutured. Depending upon clinical and/or research needs, the brain is either fixed in 20% buffered formalin or frozen. THE BRAIN CONTAINER IS SELECTED TO MAXIMIZE CONTAINMENT OF THE TISSUE.

9. The remainder of the autopsy is conducted in a modified routine manner: An organ-by-organ, in-situ examination with tissue sampling but without organ removal is recommended.

10. Decontamination of the exposed body surfaces of the body is carried out by sponging with 10% bleach. The body bag is carefully closed, sponged with bleach, and transported directly to the mortician's vehicle on a sterile cart. (It is advised that the cadaver be cremated rather than conventionally buried.)

11. Decontamination of the autopsy room involves flushing of all work surfaces and floor surfaces with 10% bleach and the autoclaving of all surgical instruments.

12. Disposable items are collected and placed in a plastic bag, sealed, and incinerated.

13. The Stryker saw is sponged with bleach.

14. Instruments are immersed in water and autoclaved at 132 degrees Celsius for one hour.

15. All washing fluids and other liquids are ultimately placed in a stoppered sink with greater than four volumes of bleach added to the final waste volume. After one hour, the sink is drained of its contents.

16. Following the decontamination procedure, the gown, mask, shoe covers, and goggles are removed and placed in double plastic bags and sealed for incineration. Finally, the gloves are removed to a red BIOHAZARD plastic bag for incineration. Call Environmental Management (ext 6662) to arrange for immediate pickup.

17. The prosector and Autopsy Assistant exit the room by walking on the bleach-soaked mat.

TISSUE PROCESSING.

18. All tissue preparations are carried out in a laminar flow hood, if available. All working materials are gathered and placed within the hood prior to tissue handling. Wear cap, gown, mask, goggles, and gloves. The use of disposable utensils is strongly advised.

19. The infected tissue is placed in a plastic Petri dish. A small portion of tissue is removed to a wax block. Thin tissue blocks are placed into labeled cassettes, which are then placed in a jar with 20% buffered phenol-formalin and transported to the processing area.

20. The hood is then decontaminated. All disposable items are placed in double plastic bags and incinerated, including clothing and gloves. Other utensils are autoclaved at 136 degrees Celsius for one hour or soaked for one hour in bleach.

21. All tissue blocks are decontaminated for routine microtomy by immersion for one hour in 96% formic acid for one hour, after formalin fixation and before routine processing.

22. The infected tissue may be processed through an automatic processor. However, the fluids in the processor must be added to four volumes of bleach before discarding, the liquid paraffin is incinerated, and the processor containers are removed and soaked in bleach. The processor itself is sponged with bleach after use.

23. The infiltrated tissue is transferred to a preheated mold containing uncontaminated liquid paraffin. The cassette mold is then snapped into place, and additional paraffin is applied. The cassette is containerized and placed in a designated refrigerator to solidify. Once the paraffin has cooled, the mold is removed and soaked in bleach or autoclaved.

24. The microtome should be in an isolated area, surrounded by absorbent material. Disposable razor blades are used to cut the block. Shavings are collected and containerized as they are produced. Flotation of sections and mounting are as usual. Paraffin blocks are resealed by reinstating into the cassette mold and filling the mold with liquid paraffin. Blocks are then stored at room temperature.

25. Staining is performed outside the hood, but separate from routine work. After use, solutions are containerized and incinerated.

26. General decontamination involves the placement of all disposable items into double plastic bags, which are then incinerated. All work surfaces are sponged with 10% bleach.

STEP-BY-STEP DESCRIPTION.
GUIDELINES FOR HIGH RISK OR POTENTIALLY HIGH-RISK AUTOPSY CASES. by Jan M Orenstein MD, PhD. Pathologist. Jan, 1984. pp. 33-34.

High-risk or potentially high-risk cases:

1. Viral hepatitis.

2. Jakob-Creutzfeldt disease.

3. Acquired Immunodeficiency Syndrome.

4. Tuberculosis.

5. Others.

General rules. If any one of these diagnoses has been seriously entertained by the clinical housestaff or is suspected during the autopsy dissection, institute the following precautions:

1. Extraordinary care must be taken to avoid accidental wounds from contaminated sharp objects.

2. Avoid production of aerosols or droplets. When sawing is necessary, use a hand saw. If a hand saw is not available, a Stryker saw can be used, but have an assistant hold a wet towel over the saw to trap dust.

3. Report all accidents immediately to Employee Health Service, to the CHIEF, AUTOPSY PATHOLOGY, available through the VAMHCS paging operator, or to the on-call attending anatomic pathologist.

4. Wear during the autopsy (preferably all disposable): Two pairs of gloves; goggles or glasses; scrubs (shirt and pants); waterproof apron; Tyvek hood or HEPA Air-Mate system. See PROCEDURE 11. AUTOPSY ROOM PROCEDURES. shoe covering; long-sleeved gown. At the completion of the autopsy, these items are to be placed in double plastic bags, sealed, and labeled as to the hazard.

5. Only the prosector, pathology attending, and autopsy assistant are permitted in the dissecting area.

6. Confine all work to the smallest possible area, do not walk around the room, do not handle telephone, and do limit potentially contaminated areas.

7. One person at a time works on the body or block. Two or more pairs of hands removing organs or dissecting in close quarters is one of the prime causes of cuts and puncture wounds.

8. All scalpel blades used at autopsy are disposable. Have a sufficient number ready at the start and only remove and change blades after they have been properly sterilized.

9. Wash all cuts or puncture wounds immediately and vigorously with iodine-based disinfectant soap (e.g., Betadine, Chlorox in case of Jakob-Creutzfeldt disease).

10. Take special care with contaminated needles. Do not bend or sheath needles after use; promptly place in puncture- resistant container filled with specific disinfectant (see below).

11. Treat all body fluids (blood, gastrointestinal contents, CSF, etc.) and tissues as potentially contaminated. Disinfect outside of all containers with appropriate agent and clearly label as to hazard, e.g., Jakob-Creutzfeldt disease, AIDS, hepatitis, etc. Precautions: unsterilized samples to be transported out of the autopsy room, e.g., cultures, chemical analysis, or material to be stored unfixed in the autopsy room, e.g., serum, are to be placed in double-containers and clearly labeled.

12. Hands must be washed after removing gowns and gloves.

13. All tissue must be fixed adequately before trimming and blocking.

SPECIAL PRECAUTIONS WITH THE FOLLOWING CASES:

JAKOB-CREUTZFELDT DISEASE (N Engl J Med 1977; 297: 1253-1258; N Engl J Med 1982; 306:1279).

Formalin does NOT kill the agent. The best inactivating agents are (1) autoclaving for one hour at 121 degrees Celsius and 15 PSI (method of choice); (2) 5.25 percent Na hypochlorite (Chlorox, standard household bleach) used at a concentration of at least 0.5 percent for at least one hour (corrosive to skin, mucous membrane, eyes, clothes, and non-stainless steel instruments). Diagnosis should be considered when evidence of intellectual deterioration, especially if associated with myoclonic activity, when no space-occupying lesion has been demonstrated on the brain. Obey all the general rules, plus: Do not begin the case without contacting the CHIEF, AUTOPSY PATHOLOGY, available through the VAMHCS paging operator, or the ON-CALL ATTENDING ANATOMIC PATHOLOGIST.

a. Limit autopsy to brain and eyes except under extraordinary situations.

b. Eliminate atomizing potentially contaminated material, e.g., tissue, body fluids. A hand saw is especially recommended for cutting bones in these cases. Be especially careful not to cut brain or spinal cord with saw.

c. Do not use running water.

d. Collect all body fluids and tissue, which are not to be saved, sterilize external surface of container and treat with hypochlorite solution (at least 0.5 percent) for a minimum of two hours, autoclave and discard, either into the drain for fluid or into 10% formalin, for tissue, which will be subsequently incinerated.

e. At conclusion of the autopsy, sponge body, table, and all contaminated surfaces (including floor if necessary) with 5.25% hypochlorite. Autoclave sponges and mops.

f. Limit instruments used. Soak in 0.5% hypochlorite for at least one hour before autoclaving. Prolonged soaking in hypocholorite solution will destroy non-stainless steel instruments; autoclaving alone may be used.

g. Fix all tissues immediately (brain and spinal cord, 20% formalin, rest 10%). For EM, use glutaraldehyde. Be sure to sterilize outside of containers and label with JAKOB-CREUTZFELDT PRECAUTIONS and DO NOT TOUCH, and store separately.

h. If specimens must be washed (from formalin), do not use running water; use several changes of fresh water which then must be sterilized with chlorox before disposal.

i. Place all contaminated gowns, sponges, masks, etc., in double Biohazard bags appropriately labeled and autoclave as recommended, then incinerate. Keep volumes down; use multiple bags if necessary.

j. Use all above precautions when handling formalin-fixed tissue, e.g., cutting brain, blocking, etc. (Remember formalin does not neutralize agent.)

k. If cut or punctured, immediately wash area vigorously with Chlorox and report incident to Employee Health Service, ext 5026, and the CHIEF, AUTOPSY PATHOLOGY, available through the VAMHCS paging operator, or to the ON-CALL ATTENDING ANATOMIC PATHOLOGIST.

l. Notify funeral home director of case and precautions.

m. For further details, See PROCEDURE 13: SAFETY POLICIES FOR CREUTZFELDT-JAKOB DISEASE.

TUBERCULOSIS. Formalin does not effectively kill Mycobacterium. (Formalin does reduce infectivity.) All exposed individuals must know status of PPD, so that if PPD is negative, they can be tested for conversion after possible exposure. Obey all general rules plus: Contaminated lung must be infiltrated with formalin and not cut for at least 48 hours. Storage must always be in a closed container, submerged, and covered with formalin-soaked towels.

HEPATITIS VIRUS. Formalin kills the virus. Prime problems are cuts and puncture wounds. Obey all general rules plus: If skin is broken by contaminated instrument, wash vigorously with iodine-based disinfectant and report incident immediately, to Employee Health Service, ext 5026, to the CHIEF, AUTOPSY PATHOLOGY, available through the VAMHCS paging operator, or to the on-call attending anatomic pathologist.

AIDS (ACQUIRED IMMUNODEFICIENCY SYNDROME). Complete autopsies will be performed when warranted. Pregnant personnel should not perform or assist with these autopsies. Contact CHIEF OF AUTOPSY SERVICE and CLINICAL PATHOLOGY MICROBIOLOGY LAB CHIEF before commencing autopsy. Removal of the thymus and, where possible, the eyes, should be part of the dissection. The disinfectant of choice is 5.25% sodium hypochlorite (standard household bleach) at a dilution of not greater than 1:10 in water. Autoclaving can also be used, 45 minutes at temperatures of at least 121 degrees Celsius and pressures of at least 20 PSI (pounds per square inch). Blood, blood products, excretions, secretions, and tissues are to be considered infectious, and direct contact with skin and mucous membranes should be avoided. Obey all general rules, plus:

1. All contacted surfaces and the outside of the body are to be washed with a 1:10 dilution of bleach.

2. Body fluids that are not to be saved and contaminated water should be treated with bleach, at a final dilution not exceeding 1:10, before disposal down the drain.

3. All tissue is to be fixed in 10% formalin either for saving or prior to incineration.

4. All reuisable instruments are to be soaked in diluted bleach for 15-30 minutes and then washed with sterilizing agents as usual. Alternatively, autoclaving can be used.

5. Place body in plastic cadaver bag, label as 'AIDS PRECAUTIONS', and notify the mortician.

6. Running water can be used to wash formalin-fixed tissues and organs.

7. If a tuberculous infection is suspected, appropriate precautions should be instituted.

REFERENCES.


1. Bastian FO, Jennings RA.
Creutzfeldt-Jakob disease. Procedures for handling diagnostic and research materials.
Infection Control. 1984;5:48-50.

2. Gajdusek DC, Gibbs CJ, Asher DM, et al.
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease).
N Engl J Med. 1977;297:1235-1238.

3. Committee on Health Care Issues, American Neurological Association.
Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease.
Ann Neurol. 1986;19:75-77.

4. Tateischi J, Takatoshi T, Tetsuyuki K.
Inactivation of the Creutzfeldt-Jakob disease agent.
Ann Neurol. 1988;24:466.


5. Tami Y, Fumiaki T, Sadanori M.
Inactivation of the Creutzfeldt-Jakob disease agent.
Ann Neurol. 1988;24:466-467.


6. Bell JE, Ironside JW.
How to tackle a possible Creutzfeld-Jakob disease necropsy.
J Clin Pathol. 1993;46:193-197.


7. Miller DC.
Creutzfeldt-Jakob disease in histopathology technicians.
New Engl J Med. 1988;318:853-584.


8. Gorman DG, Benson DF, Vogel DG, Vinters HV.
Creutzfeldt-Jakob disease in a pathologist.
Neurology. 1992;42:463.


9. Jakob-Creutzfeldt disease.
N Engl J Med. 1977; 297: 1253-1258;
N Engl J Med. 1982; 306:1279.


10. Orenstein JM.
Guidelines for high risk or potentially high-risk autopsy cases.
Pathologist. Jan, 1984. pp. 33-34.


11. Steelman VM.
Creutzfeldt-Jakob disease: recommendations for infection control.
Am J Infect Control. 1994 Oct;22(5):312-318.
"Creutzfeldt-Jakob disease, an infectious, progressive, degenerative neurologic disorder, has a presumably long incubation period but a rapid, fatal course. Brain tissue at autopsy resembles that seen in spongioform encephalopathies of other species. Creutzfeldt-Jakob disease is transmitted by a proteinaceous infectious agent, or `prion'. Epidemiologic patterns remain uncertain; various studies have reported conflicting risk factors in different populations, and genetic susceptibility may be involved. Although natural transmission routes are still unclear, both iatrogenic and nosocomial transmissions have been identified. Transmission has occurred through contaminated electrodes, contaminated biologic products from cadaveric brains, and infected donor tissues, including dura mater and corneas. Because the prion is difficult to eradicate, stringent sterilization precautions must be taken with all surgical instruments. Some tissues and body fluids (e.g., brain, ocular, central nervous system) from the patient with Creutzfeldt-Jakob disease are highly infectious, and must be contained or incinerated. Some body fluids, however, are not considered infectious. Persons with known or suspected Creutzfeldt-Jakob disease, or with exposure to potential sources of iatrogenic infection, should not be considered as donors for any tissues or biologic products. Occupational transmission to health care and pathology workers is also possible. Therefore, specific preventive measures are necessary. Many questions remain regarding transmission and risk factors for Creutzfeldt-Jakob syndrome, and the precautions presented here must be considered only preliminary."

PMID: 7847639
Show abstract.

12. Duckett S, Stern J.
Origins of the Creutzfeldt and Jakob concept.
J Hist Neurosci. 1999 Apr;8(1):21-34.
"A review of the publications of Hans Creutzfeldt and Alfons Jakob, pertaining to the concept which bears their name (CJD), reveals that they described a neuropathological syndrome, and were opposed to its classification as a neurological disease. The evidence on which Creutzfeldt and Jakob based their view is reevaluated, and studies by other workers are cited in which a range of environmental and genetic factors generated the CJ syndrome, challenging the proposition that CJD is a disease with a single cause."

PMID: 11624133
Show abstract.

13. FACTSHEET:CREUTZFELDT-JAKOB DISEASE.
Citation: NSW Public Health Bulletin 2001; 12(2): 43.
WHAT IS CREUTZFELDT-JAKOB DISEASE? "Creutzfeldt-Jakob disease (CJD) is a rare and fatal brain disease in humans. It is a type of disease known as a transmissible spongiform encephalopathy (TSE) because it causes characteristic spongy breakdown of the brain and it can be transmitted. Other animals-such as sheep, cows and cats-can also develop TSEs.

THE FOUR MAIN TYPES OF CJD. Sporadic (classical) CJD. "This is the most common form, responsible for 85 per cent of cases. The cause is unknown. It mainly affects people aged over 50 years.

Familial CJD. "This is an inherited form of the disease with a younger age of onset. It causes 10-15 per cent of cases of CJD.

Iatrogenic CJD. "This occurs through the inadvertent use of infectious material in medical procedures.

Variant CJD. "This is a newly-recognised type that was first discovered in 1996 in the United Kingdom. It is caused by the same infectious agent that causes 'mad cow disease' (BSE or Bovine Spongiform Encephalopathy) that has affected cattle in the United Kingdom and other parts of Europe. It is different to sporadic CJD because it usually affects younger people, who have a longer duration of illness. It also has slightly different clinical features and can be distinguished from sporadic CJD by postmortem laboratory examination of brain tissue (that is, after the person has died). Evidence of the infection can also be found in lymph tissue, such as tonsils.

WHAT CAUSES CJD? "It is thought that an infectious agent, known as a prion, causes the damage to the brain. Prions are different to other infectious agents (such as bacteria and viruses) because they are made from a protein that is normally present in all cells. It is believed that the prion causes normal cell proteins to change into abnormal cell proteins, and that these build up in the brain, causing damage.

"In inherited CJD the genes that tell the body how to make the protein may be faulty. In iatrogenic CJD the abnormal protein comes from contaminated tissue or instruments. Variant CJD is thought to occur when the prion is ingested in contaminated beef or beef products. It is unclear if other risk factors or predisposing factors are needed to enable the prion to cause disease. In sporadic CJD no one knows how the abnormal protein arises.

HOW COMMON IS CJD? "CJD is rare. It occurs worldwide at a rate of 0.5 to 1 case per million per year. Overall, Australia has about the same case rate as other countries. Because of the relationship with Bovine Spongiform Encephalopathy, most cases of variant CJD have occurred in the United Kingdom (a total of 85 cases as of November 2000). An additional three cases have been reported in France and one in Ireland. Because CJD can have an incubation period of many years, it is unclear how many new cases of variant CJD will occur. As of February, 2001, no cases of variant CJD or BSE have been reported in Australia.

WHAT ARE THE SYMPTOMS OF CJD? "CJD causes progressive symptoms of difficulty with coordination, muscle jerks and memory loss with eventual dementia. Variant CJD can also cause mood disturbance and altered sensations. CJD is fatal, usually within a year of onset of symptoms. At present there is no cure. Treatments for symptoms such as pain and muscle jerks are very important in caring for people with CJD.

HOW IS CJD DIAGNOSED? "A definite diagnosis can only be made by examining brain tissue after death. There are, however, other tests such as CAT scans, MRI scans, and EEGs, that can be highly suggestive of the diagnosis and are used to rule out other diagnoses. People with variant CJD may have the prion protein present in their tonsils and other tissues.

CAN YOU CATCH CJD? "In Australia, iatrogenic CJD has been caused by the use of human growth hormone taken from the pituitary glands of cadavers that are infected with CJD. Currently, as there is no Bovine Spongiform Encephalopathy in Australian cattle, no risk is posed by eating Australian beef or beef products. Beef and beef products from countries with infected cattle have been banned from import to Australia.

"There is no evidence that sporadic CJD is spread by blood transfusion. There is a theoretical possibility that variant CJD could be transmitted by blood transfusion, although this has never been reported. As a precautionary measure, people who have spent six months or more in Great Britain between 1980 and 1996 cannot donate blood. This is because beef and beef products consumed in Great Britain during this time could have come from cows harbouring BSE infection. Regular surveillance for BSE in cattle is carried out routinely in Australia.

"There is no evidence that CJD can be transmitted by normal social contact."


Page Owner: NSW Public Health Bulletin. (New South Wales, Australia).
Last Updated : Tuesday, 02-Oct-01 12:57:20
http://www.health.nsw.gov.au/public-health/phb/feb01html/factsheetfeb01.html

14. Will RG, Matthews WB.
A retrospective study of Creutzfeldt-Jakob disease in England and Wales, 1970-1979. 1: Clinical features.
J Neurol Neurosurg Psychiatry. 1984;47:134-140.


15. Hansen LA, Maslish M, Terry RD, Mirra SS.
A neuropathologic subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change.
Acta Neuropathol. 1989;78:194-291.


16. Prusiner SB.
Molecular biology of prion diseases.
Science. 1991;252:1515-1522.


17. Penar PL, Prichard JW.
Jakob-Creutzfeldt diseaes associated with cadaveric dura.
J Neurosurg. 1987;67:149.


18. Buchanan CR, Preece MA, Milner RDG.
Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growh hormone in the United Kingdom.
BMJ. 1991;302:824-828.


19. Prusiner SB.
Prions and neurodegenerative diseases.
N Engl J Med. 1987;317:1571-1581.


20. Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL.
Prion dementia without characteristic pathology.
Lancet. 1990;336:7-9.


21. Will RG.
The spongiform encephalopathies.
J Neurol Neurosurg Psychiatry. 1991;54:761-763.


22. Bell JE, Ironside JW.
Department of Health National Surveillance of Creutzfeldt-Jakob Disease.
Bull R Coll Pathol. 1991;74:9-10.


23. Traub RD, Gajdusek DC, Gibbs CJ jr.
Precautions in autopsies on Creutzfeldt-Jakob disease.
Am J Clin Pathol. 1973;64:287.


24. American Neurological Association. Committee on Health Care Issues.
Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeld-Jakob disease.
Ann Neurol. 1986;19:75-77.


25. Taylor DM.
Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity.
Neuropathol Appl Neurobiol. 1989;15:585-586.

26. Brown P, Wolff A, Gajdusek DC.
A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.
Neurology. 1990;40:887-890.

27. MacArthur S, Jacobson R, Marrero H, et al.
Autopsy removal of the brain in AIDS: a new technique.
Hum Pathol. 1986;17:1296-1297.